Navigation Links
Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development
Date:2/11/2008

Company Also Provides Update on DARA Program's Ongoing Phase 2a

Hypertension Study

PRINCETON, N.J., Feb. 11 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced the nomination of PS031291 as a preclinical development compound from its internal CCR1 discovery program. PS031291 is a potent and highly selective antagonist at the chemokine receptor CCR1, which has been implicated to play a significant role in multiple inflammatory and autoimmune disease processes. Pharmacopeia believes PS031291 may possess significant potential in the oral treatment of multiple myeloma and various inflammatory diseases including rheumatoid arthritis. The company intends to initiate GLP toxicology studies on the compound in the current quarter.

"PS031291 strengthens Pharmacopeia's internal pipeline with a wholly-owned development candidate with the potential to address significant therapeutic needs," said Les Browne, Ph.D., President and Chief Executive Officer of Pharmacopeia. "We believe this nomination is a testament to our drug discovery expertise which has already generated a number of clinical compounds for our strategic partners."

While a number of compounds discovered by Pharmacopeia are being developed by its various collaborators, PS031291 is the first compound to emerge from Pharmacopeia's internal drug discovery efforts into its internal development portfolio. Pharmacopeia's internal clinical pipeline consists of PS433540 (DARA) for hypertension and diabetic nephropathy and PS178990 (SARM) for muscle wasting associated with a number of serious medical conditions including end-stage renal disease
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmacopeia to Present at BIO CEO & Investor Conference 2008
2. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
3. Pharmacopeia Announces Third Quarter 2007 Financial Results
4. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
5. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
6. Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)
7. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
10. Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells
11. CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... PLAINSBORO, N.J. , April 28, 2015 /PRNewswire-USNewswire/ ... treatments but they also require more of manufacturers, ... Times , the specialty pharmacy field,s premiere journal, ... Pharmacy (NASP), the only national trade association dedicated ... pharmacy businesses and clinicians to fill this growing ...
(Date:4/28/2015)... , April 28, 2015 Semler Scientific, Inc. ... company that develops, manufactures and markets patented products that ... diseases, today announced that it has received an order ... in the country who offer Medicare Advantage programs. This ... 15 insurance plans who are now customers of Semler. ...
(Date:4/28/2015)... , April 28, 2015  Olympus, a precision technology ... and surgical procedures, among other core businesses, announced today ... Brooklyn Park, MN. The new ... designed to position the company for continued long-term growth ... dedication ceremony took place on April 27 and was ...
Breaking Medicine Technology:Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 2Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 3Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 4Semler Adds Top Insurance Plan to Customer List 2Semler Adds Top Insurance Plan to Customer List 3Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 2Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 3Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 4
(Date:4/28/2015)... Hellen Chen, who is a bestselling author and marriage guru, ... study conducted by Washington University, between 1991 and ... by 20% while the number of unfaithful husbands has increased ... this year from the Journal of Marital and ... spouses admit to infidelity, either physical or emotional is 41%. ...
(Date:4/28/2015)... Colorado (PRWEB) April 28, 2015 Colorado ... an updated version of his popular spine education website ... ASKSPINEDOC.COM developed by eMedical Media. This website has ... of the anatomy of the spine, causes of neck ... Dr. Corenman created this website and personally answers questions ...
(Date:4/28/2015)... SeniorCare.com has published the Misconception ... problem Americans have regarding aging and long-term care needs. ... services as they age, 63% of Americans do NOT ... the report, Carol Marak of SeniorCare.com interviewed 44 senior ... Care Association and The Scan Foundation. The experts discuss ...
(Date:4/28/2015)... 2015 Wimbledon Health Partners, the ... electrocardiogram, echocardiogram, and NCV testing, has expanded their ... help podiatrists diagnose peripheral arterial disease (PAD). ... without the aid of vascular testing,” said ... at Wimbledon Health Partners. “Diminished peripheral pulses, atrophic ...
(Date:4/28/2015)... Saint Louis, MO (PRWEB) April 28, 2015 ... May 6, 2015 from 5:00 to 8:00 pm at the ... 01880. More than 50 hospitals, clinics and groups with career ... will be represented. Attendees will enjoy free hors d’oeuvres and ... for PracticeMatch says “Boston is an ideal location ...
Breaking Medicine News(10 mins):Health News:Why Do Some Good Women and Men End Up Breaking Others' Marriages? 2Health News:Why Do Some Good Women and Men End Up Breaking Others' Marriages? 3Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 2Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 3Health News:SeniorCare.com Report: America Has a Major Misconception on Aging 2Health News:Podiatrists Affiliate with Wimbledon Health Partners to Diagnose Peripheral Arterial Disease 2Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 2Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 3
... ... hindsight could soon be 20/10. He believes that vision beyond 20/20 is possible and technological ... , ... has been the hallmark of perfect vision. That Bar is about to be raised., , ,Dr. ...
... ... dental tourism facilitator specializing only in dentistry that is dedicated to helping patients receive ... ... years of expensive visits to the dentist, Jeff Apton emerged from retirement to start ...
... , LOS ANGELES ... with California,s three regional Hospital Associations, and the National ... three-year, 6 million dollar effort to improve the quality ... Center hosted the launch of Patient Safety First... a California ...
... , Jan. 19 As they rush to save ... workers also must address myths about disaster relief among the American ... World Vision, debunks five myths around disaster relief. , 1. ... , The cost of shipping these items from around the ...
... , PORTLAND, Ore. , Jan. 18 ... , The Regence Foundation donated $50,000 to Medical Teams ... trained volunteers to provide medical assistance to areas throughout the world. ... desperately needed help. , "It is difficult to comprehend the loss ...
... , , SCHAFFHAUSEN, Switzerland , ... today that it now expects to report diluted earnings per share from ... in the range of $0.63 to $0.65 per share or ... to the company,s previous guidance for diluted earnings per share from continuing ...
Cached Medicine News:Health News:20/10 Vision in the Year 2010: Is "HD Vision" Beyond 20/20 a Reality? 2Health News:20/10 Vision in the Year 2010: Is "HD Vision" Beyond 20/20 a Reality? 3Health News:Snatched from the Jaws of Retirement: Spiraling Treatment Costs Push Senior To Start Pan American Dental Tours 2Health News:Snatched from the Jaws of Retirement: Spiraling Treatment Costs Push Senior To Start Pan American Dental Tours 3Health News:Anthem Blue Cross Partners With California Regional Hospital Associations and The National Health Foundation To Launch an Historic Three-Year Statewide Patient Safety Collaborative 2Health News:Anthem Blue Cross Partners With California Regional Hospital Associations and The National Health Foundation To Launch an Historic Three-Year Statewide Patient Safety Collaborative 3Health News:Anthem Blue Cross Partners With California Regional Hospital Associations and The National Health Foundation To Launch an Historic Three-Year Statewide Patient Safety Collaborative 4Health News:Anthem Blue Cross Partners With California Regional Hospital Associations and The National Health Foundation To Launch an Historic Three-Year Statewide Patient Safety Collaborative 5Health News:Myths of Disaster Relief 2Health News:Myths of Disaster Relief 3Health News:Regence Foundation Donates $50,000 to Aid Haiti Relief Efforts 2Health News:Tyco International Provides Update on First Quarter 2010 Performance 2Health News:Tyco International Provides Update on First Quarter 2010 Performance 3Health News:Tyco International Provides Update on First Quarter 2010 Performance 4Health News:Tyco International Provides Update on First Quarter 2010 Performance 5
QC HGB is an assayed quality control material for Hemocue analyzers. This control is a solution of stabilized human red cells and is available in 3 levels for monitoring analyzer performance at sever...
VertiGraft allografts for spine surgery deliver the strength adn performance you demand in your procedures and they are backed by quality and safety standards that are unmatched in the industry....
... for every general surgery need. No matter ... the GO450/GO400 Omni-Flex™ General Retractor Systems give ... the best possible exposure in the simplest ... and the hinged extension arm, the GO450 ...
Specifically designed to address the requirements of spine specialists performing vertebroplasty or kyphoplasty procedures....
Medicine Products: